
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1039 | 992 | 979 | 916 | 1232 | 1856 |
Fund Return | 3.88% | -0.77% | -2.12% | -2.87% | 4.27% | 6.38% |
Place in category | 26 | 49 | 107 | 81 | 50 | 12 |
% in Category | 18 | 45 | 85 | 68 | 53 | 15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Oppenheimer Main Street A | 9.07B | 2.34 | 10.43 | 11.12 | ||
Oppenheimer Developing Markets Y | 8.01B | 1.76 | -1.74 | 2.18 | ||
Oppenheimer Global A | 5.82B | 1.85 | 8.59 | 9.11 | ||
Oppenheimer Developing Markets I | 5.29B | 1.79 | -1.59 | 2.34 | ||
Oppenheimer Capital Appreciation A | 4.79B | -2.05 | 11.98 | 12.27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFS International New Discovery R6 | 4.96B | 1.92 | 1.31 | 4.72 | ||
Fidelity Series International Sm C | 3.82B | 3.58 | 3.68 | 7.33 | ||
T. Rowe Price International Discove | 3.52B | 2.00 | -0.83 | - | ||
Artisan International Small Cap Ins | 3.11B | 1.49 | -0.40 | - | ||
T. Rowe Price International Discov | 2.02B | 1.99 | -0.98 | 6.62 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Carl Zeiss AG | DE0005313704 | 2.59 | 66.700 | -3.33% | |
Obic Co Ltd | JP3173400007 | 2.42 | 4,326.0 | -0.25% | |
Partners Group | CH0024608827 | 2.18 | 1,337.00 | -0.48% | |
Azbil Corp | JP3937200008 | 1.70 | 1,210.0 | +0.41% | |
ChemoMetec | DK0060055861 | 1.60 | 511.50 | -1.54% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Sell | Strong Sell |
Technical Indicators | Strong Buy | Strong Buy | Strong Sell |
Summary | Strong Buy | Neutral | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review